申请人:Saha Uttam
公开号:US20090082317A1
公开(公告)日:2009-03-26
The present invention provides novel 16,23-diene 25-oxime ether analogs of 1,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the novel compound of the invention are useful for treating diseases which benefit from a modulation of the levels of 1,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.
本发明提供了一种新颖的1,25-二羟基维生素D3的16,23-二烯-25-氧基醚类似物,包括含有这些化合物的组合物以及将这些化合物用作CYP24抑制剂的方法。特别是,本发明的这种新颖化合物对于治疗受益于调节1,25-二羟基维生素D3水平的疾病是有用的,例如,细胞增殖紊乱。